Logo
En | De
know what's inside:

All posts

8/26/2019

Dr. Heike Schmidt-Eisenlohr of GBA Pharma Labs speaking at 6th European Forum.

From September 25th to September 26th the 6th European Forum on Extractables, Leachables, Medial Devices and Contact Materials Testing take place in Hamburg. The forum focuses on industry testing requirements for the identification and characterization of extractable, leachable (E&L), and non-intentionally added substances (NIAS) contaminants. Presentations from leaders in their field takes place over 2 days. On the 2nd day Dr. Heike Schmidt-Eisenlohr, expert for E&L studies at GBA Pharma Labs, presents a speech on ‘Extractable & Leachable Study with Integrity Testing & Toxicological Assessment’.

more
5/13/2019

Dr. Xaver Schratt from GBA Pharma Labs speaking at Impurities Forum 2019.

From September 25th to September 26th the 6th European Forum on Extractables, Leachables, Medial Devices and Contact Materials Testing take place in Hamburg. The forum focuses on industry testing requirements for the identification and characterization of extractable, leachable (E&L), and non-intentionally added substances (NIAS) contaminants. Presentations from leaders in their field takes place over 2 days. On the 2nd day Dr. Heike Schmidt-Eisenlohr, expert for E&L studies at GBA Pharma Labs, presents a speech on ‘Extractable & Leachable Study with Integrity Testing & Toxicological Assessment’.

more
4/15/2019

Pharmaceutical Industry Brexit Update: Extension of the period under ‘Article 50’

The European Council agreed to a further extension of the date for the UK’s withdrawal from the EU at its meeting on 10-11 April. The extension will last as long as necessary and, in any event, no longer than 31 October 2019. EMA calls on all pharmaceutical companies to continue their preparedness for the UK’s withdrawal.

more
© 2020 GBA Group
Data PrivacyLegal NoticeTerms& ConditionsDisclosure